Beni-Suef University
bsu.edu.egTotal trials
291
Active
66
Phase 3
38
Total enrollment
66,869
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 40 of 47 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ventoline® Evohaler® 100 µg/inhalation pMDI alone | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to Able spacer | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connectec to Tips-Haler spacer | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to Aerochamber plus flow vu valved holding chamber | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to Atomizer chamber spacer | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to plastic juice cup spacer | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to the DispozABLE spacer | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to the Lite-Aire collapsible valved holding chamber spacer | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to the MDI package | — | — | — | — | — | 1 | |
| Ventoline® Evohaler® 100 µg/inhalation pMDI connected to the hand-made paper sheet spacer | — | — | — | — | — | 1 | |
| Clindamycin vaginal cream | — | — | — | — | — | 1 | |
| Vaginal preparation with povidone- iodide solution 10 % | — | — | — | — | — | 1 | |
| Colistimethate Sodium | — | — | — | — | — | 1 | |
| Tigecycline | — | — | — | — | — | 1 | |
| Tadalafil 5mg | — | — | — | — | — | 1 | |
| estradiol valerate 2 mg | — | — | — | — | — | 1 | |
| diosmin/hesperdin | — | — | — | — | — | 1 | |
| Myoinositol | — | — | — | — | — | 2 | |
| Letrozole 2.5mg | — | — | — | — | 3 | ||
| Metformin | — | — | — | — | 3 | ||
| Dapagliflozin/Metformin | — | — | — | — | — | 2 | |
| Probiotic Formula | — | — | — | — | — | 1 | |
| Control | — | — | — | — | — | 1 | |
| pentoxifylline 400 mg | — | — | — | — | — | 1 | |
| Co-Enzyme Q10 | — | — | — | — | — | 1 | |
| Melatonin | — | — | — | — | — | 1 | |
| Folic acid | — | — | — | — | — | 1 | |
| Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day. | — | — | — | — | — | 1 | |
| DHEA plus folic acid 400mcg per day | — | — | — | — | — | 1 | |
| Inhaled nitroglycerin | — | — | — | — | — | 1 | |
| Dapagliflozin | — | — | — | — | — | 1 | |
| Letrozole | — | — | — | — | — | 1 | |
| Chromium | — | — | — | — | — | 1 | |
| l-arginine | — | — | — | — | — | 1 | |
| Control group | — | — | — | — | 3 | ||
| Conventional pharmacological therapy | — | — | — | — | — | 1 | |
| tadalafil 20 mg then 40 mg if tolerated | — | — | — | — | — | 1 | |
| GLP-1 analog | — | — | — | — | — | 1 | |
| SGLT2 inhibitor | — | — | — | — | — | 1 | |
| Antidiabetic | — | — | — | — | — | 1 |
7 more active programs hidden
Next readouts
- 2024-12-30
- 2024-12-30
- 2024-12-31
- 2025-02-10
- 2025-04-26
- 2025-05-30
- 2025-10-01
- 2025-12-30
- 2026-01-28
- 2026-02-15
Top conditions
- IVF8
- Pain5
- Breast Cancer5
- Chronic Hepatitis C Virus Infection4
- Patient Satisfaction3
- Educational Problems3
- Covid193
- Cerebral Palsy3
Frequently asked questions about Beni-Suef University
- How many clinical trials does Beni-Suef University have on ClinicalTrials.gov?
- Beni-Suef University is listed as the lead sponsor on 291 clinical trials in ClinicalTrials.gov, 66 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Beni-Suef University's trials are in Phase 3?
- 38 of Beni-Suef University's trials are in Phase 3, spread across 47 active drug programs.
- What therapeutic areas does Beni-Suef University focus on?
- Beni-Suef University's most-studied conditions on ClinicalTrials.gov are IVF, Pain, Breast Cancer, Chronic Hepatitis C Virus Infection, Patient Satisfaction.
- When are Beni-Suef University's next clinical trial readouts?
- Beni-Suef University has 10 upcoming primary-completion readouts tracked here; the soonest is “of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve”, expected around 2024-12-30.